Teleflex, Inc. (TFX)
126.17
-1.08
(-0.85%)
USD |
NYSE |
Dec 12, 09:55
Teleflex Research and Development Expense (Quarterly): 57.23M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| Repligen Corp. | 14.18M |
| Globus Medical, Inc. | 38.07M |
| Tandem Diabetes Care, Inc. | 47.88M |
| Elutia, Inc. | 1.088M |